Published in Neurology on October 09, 2001
Genetic association studies: genes in search of diseases. Neurology (2001) 1.65
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet (2001) 1.30
The biopsychosocial effects of restless legs syndrome (RLS). Neuropsychiatr Dis Treat (2006) 0.89
Restless legs syndrome induced by topiramate: two more cases. J Neurol (2009) 0.80
A novel locus for restless legs syndrome maps to chromosome 19p in an Irish pedigree. Neurogenetics (2012) 0.80
Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism. Psychiatry Investig (2009) 0.77
Genetic aspects of restless legs syndrome. Postgrad Med J (2006) 0.75
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet (1996) 4.16
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology (2008) 3.62
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet (2001) 3.59
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry (2007) 3.49
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature (1988) 3.27
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology (1992) 3.08
Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene (2009) 2.74
Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis (2010) 2.69
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet (1998) 2.51
Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry (1999) 2.45
REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology (2002) 2.44
Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci (2001) 2.43
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature (1987) 2.32
REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry (2008) 2.22
Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology (2007) 2.15
The effects of pramipexole in REM sleep behavior disorder. Neurology (2003) 2.10
Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet (2008) 2.00
Personality traits as correlates of suicidal ideation, suicide attempts, and suicide completions: a systematic review. Acta Psychiatr Scand (2006) 1.99
Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology (2001) 1.95
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology (2007) 1.95
Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology (2009) 1.87
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Polyglutamine-containing proteins in schizophrenia. Mol Psychiatry (1999) 1.77
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene (2010) 1.75
Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology (2000) 1.73
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70
Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet (2000) 1.70
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry (2010) 1.69
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep (2000) 1.66
Chloroplast and nuclear gene sequences indicate late Pennsylvanian time for the last common ancestor of extant seed plants. Proc Natl Acad Sci U S A (1994) 1.66
Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ (2013) 1.64
EEG and cardiac activation during periodic leg movements in sleep: support for a hierarchy of arousal responses. Neurology (1999) 1.62
Development of sleep patterns in early adolescence. J Sleep Res (2001) 1.61
Impulsive-aggressive behaviours and completed suicide across the life cycle: a predisposition for younger age of suicide. Psychol Med (2007) 1.59
Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol (1993) 1.59
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry (2003) 1.58
Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol (1991) 1.57
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol (2001) 1.55
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology (1996) 1.50
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49
Slow-wave activity in sleep apnea patients before and after continuous positive airway pressure treatment: contribution to daytime sleepiness. Chest (2001) 1.49
Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry (2007) 1.47
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry (2007) 1.45
Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology (1987) 1.45
Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene (2011) 1.43
Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.42
Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet (2000) 1.42
Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics (2001) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Nocturnal asthma: features of attacks, sleep and breathing patterns. Am Rev Respir Dis (1982) 1.41
The effects of L-dopa on excessive daytime sleepiness in narcolepsy. Neurology (1991) 1.41
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry (2011) 1.40
Lack of association between bipolar disorder and tyrosine hydroxylase: a meta-analysis. Am J Med Genet (1997) 1.40
Recent advances in the genetics of distal hereditary motor neuropathy give insight to a disease mechanism involving copper homeostasis that may extend to other motor neuron disorders. Clin Genet (2011) 1.39
Age-related modifications of NREM sleep EEG: from childhood to middle age. J Sleep Res (2001) 1.37
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry (2003) 1.37
Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep (2000) 1.37
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J (2001) 1.37
Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology (1996) 1.36
Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology (2008) 1.35
Sleep spindle characteristics in healthy subjects of different age groups. Clin Neurophysiol (2001) 1.34
Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci (1997) 1.33
Schizophrenia and chromosome 6p. Am J Med Genet (1997) 1.31
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet (2001) 1.30
Development of parasomnias from childhood to early adolescence. Pediatrics (2000) 1.29
Cerebral cavernous malformations: mutations in Krit1. Neurology (2002) 1.27
Oculopharyngeal muscular dystrophy. Semin Neurol (1999) 1.27
Excess of deletions of maternal origin in the DiGeorge/velo-cardio-facial syndromes. A study of 22 new patients and review of the literature. Hum Genet (1995) 1.25
Neurobiology of sleep disturbances in neurodegenerative disorders. Curr Pharm Des (2008) 1.24
RAPDs as an aid to evaluate the genetic integrity of somatic embryogenesis-derived populations of Picea mariana (Mill.) B.S.P. Theor Appl Genet (1993) 1.22
Cloning of a balanced translocation breakpoint in the DiGeorge syndrome critical region and isolation of a novel potential adhesion receptor gene in its vicinity. Hum Mol Genet (1995) 1.20
Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation. Neurology (2002) 1.20
Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum Mol Genet (2001) 1.19
The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet (1994) 1.19
Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet (1993) 1.19
Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med (1988) 1.18
Epigenetic regulation of BDNF expression according to antidepressant response. Mol Psychiatry (2012) 1.18
Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology (1985) 1.17
Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry (2001) 1.16
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death Differ (2013) 1.13
Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res (1990) 1.13
Genetic diversity and phylogenetic relationships between birches and alders using ITS, 18S rRNA and rbcL gene sequences. Mol Phylogenet Evol (1993) 1.11
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci (1999) 1.10
The gene responsible for Clouston hidrotic ectodermal dysplasia maps to the pericentromeric region of chromosome 13q. Hum Mol Genet (1996) 1.09
The gene responsible for a severe form of peripheral neuropathy and agenesis of the corpus callosum maps to chromosome 15q. Am J Hum Genet (1996) 1.09
Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet (1997) 1.09
CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet (2000) 1.09